Подписаться
Pasquale Niscola
Pasquale Niscola
Dirigente Medico, UOC Ematologia, Day Hospital Ematologico CTO, Ospedale S.Eugenio-CTO (ASL Roma 2
Подтвержден адрес электронной почты в домене aslroma2.it
Название
Процитировано
Процитировано
Год
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
RV Lalla, J Bowen, A Barasch, L Elting, J Epstein, DM Keefe, DB McGuire, ...
Cancer 120 (10), 1453-1461, 2014
12612014
Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients
W Barcellini, B Fattizzo, A Zaninoni, T Radice, I Nichele, E Di Bona, ...
Blood, The Journal of the American Society of Hematology 124 (19), 2930-2936, 2014
3992014
Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia
MI Del Principe, G Del Poeta, F Buccisano, L Maurillo, A Venditti, ...
Blood 108 (3), 853-861, 2006
2422006
Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases
M Federico, U Vitolo, PL Zinzani, T Chisesi, V Clo, G Bellesi, M Magagnoli, ...
Blood, The Journal of the American Society of Hematology 95 (3), 783-789, 2000
2352000
Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 …
EN Oliva, C Alati, V Santini, A Poloni, A Molteni, P Niscola, F Salvi, ...
The Lancet Haematology 4 (3), e127-e136, 2017
1862017
Mucositis in patients with hematologic malignancies: an overview
P Niscola, C Romani, L Cupelli, L Scaramucci, A Tendas, T Dentamaro, ...
Haematologica 92 (2), 222-231, 2007
1852007
Revised International Prognostic Scoring System (IPSS) predicts survival and leukemic evolution of myelodysplastic syndromes significantly better than IPSS and WHO Prognostic …
MT Voso, S Fenu, R Latagliata, F Buccisano, A Piciocchi, MA Aloe-Spiriti, ...
Journal of Clinical Oncology 31 (21), 2671-2677, 2013
1812013
Systematic review of amifostine for the management of oral mucositis in cancer patients
O Nicolatou-Galitis, T Sarri, J Bowen, M Di Palma, VE Kouloulias, ...
Supportive Care in Cancer 21, 357-364, 2013
1632013
Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients
O Nicolatou-Galitis, T Sarri, J Bowen, M Di Palma, VE Kouloulias, ...
Supportive Care in Cancer 21, 3179-3189, 2013
1512013
Characteristics and outcome of therapy‐related myeloid neoplasms: Report from the I talian network on secondary leukemias
L Fianchi, L Pagano, A Piciocchi, A Candoni, G Gaidano, M Breccia, ...
American journal of hematology 90 (5), E80-E85, 2015
1242015
Impact of a new dosing regimen of epoetin alfa on quality of life and anemia in patients with low-risk myelodysplastic syndrome
MAA Spiriti, R Latagliata, P Niscola, A Cortelezzi, M Francesconi, ...
Annals of Hematology 84, 167-176, 2005
1202005
The use of major analgesics in patients with renal dysfunction
P Niscola, L Scaramucci, G Vischini, M Giovannini, M Ferrannini, P Massa, ...
Current drug targets 11 (6), 752-758, 2010
972010
Pain syndromes in sickle cell disease: an update
P Niscola, F Sorrentino, L Scaramucci, P De Fabritiis, P Cianciulli
Pain Medicine 10 (3), 470-480, 2009
922009
Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort study
F Efficace, G Gaidano, M Breccia, MT Voso, F Cottone, E Angelucci, ...
The Lancet Oncology 16 (15), 1506-1514, 2015
892015
Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes
F Efficace, G Gaidano, M Breccia, M Criscuolo, F Cottone, G Caocci, ...
British journal of haematology 168 (3), 361-370, 2015
812015
Prospective international validation of the Quality of Life in Myelodysplasia Scale (QUALMS)
GA Abel, F Efficace, RJ Buckstein, S Tinsley, JG Jurcic, Y Martins, ...
Haematologica 101 (6), 781, 2016
772016
Fulminant B hepatitis in a surface antigen-negative patient with B-cell chronic lymphocytic leukaemia after rituximab therapy
P Niscola, MI Del Principe, L Maurillo, A Venditti, F Buccisano, D Piccioni, ...
Leukemia 19 (10), 1840-1841, 2005
692005
Hemorrhagic complications in patients with advanced hematological malignancies followed at home: an Italian experience
C Cartoni, P Niscola, M Breccia, G Brunetti, GM D'Elia, M Giovannini, ...
Leukemia & lymphoma 50 (3), 387-391, 2009
652009
Pain and anxiety associated with bone marrow aspiration and biopsy: a prospective study on 152 Italian patients with hematological malignancies
GA Brunetti, A Tendas, E Meloni, D Mancini, P Maggiore, L Scaramucci, ...
Annals of hematology 90, 1233-1235, 2011
622011
TP53 Mutations in Acute Myeloid Leukemia: Still a Daunting Challenge?
M Molica, C Mazzone, P Niscola, P De Fabritiis
Frontiers in oncology 10, 610820, 2021
612021
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20